The American Society of Clinical Oncology and the College of American Pathologists Guideline Recommendations state that the cutoff for positive ER or PR should be ≥1% of immunoreactive tumor cell nuclei (the previous threshold was >10%) [10]. The gene discussed is ESR1; the disease is neoplasm.